<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="osanctum-searched/PMC5093107/results/search/drugs/results.xml">
  <result pre="agent have been reported [ 14, 15]. The degradation of" exact="phenol" post="red by palladium nanoparticles has been investigated. The nanoparticles"/>
  <result pre="palladium nanoparticles has been investigated. The nanoparticles were added to" exact="phenol" post="red and stirred at room temperature at varying pH"/>
  <result pre="433 nm disappeared at pH 6 showing the degradation of" exact="phenol" post="red [ 15]. Palladium nanoparticles synthesized from aqueous leaf"/>
  <result pre="for PdCl 4 2−/HAuCl 4, followed by the reduction of" exact="ascorbic acid" post="and production of Pt-Au-PDA/RGO. It is not a convincing"/>
  <result pre="as the reducing agent, obviously there is no need of" exact="ascorbic acid" post="as a secondary reductant for the production of nanoparticles"/>
  <result pre="production of nanoparticles from H 2PdCl 4/HAuCl 4. Besides, how" exact="ascorbic acid" post="is reduced when it is a well-known reducing agent."/>
  <result pre="agent. Naturally, the PDA would act as a stabilizer and" exact="ascorbic acid" post="as a reducing agent. The catalytic activity of monometallic"/>
  <result pre="therapeutic agents [ 63– 70]. Platinum compounds such as cis-platin," exact="carboplatin" post="and oxaliplatin are frequently used in chemotherapy especially in"/>
  <result pre="[ 63– 70]. Platinum compounds such as cis-platin, carboplatin and" exact="oxaliplatin" post="are frequently used in chemotherapy especially in the treatment"/>
  <result pre="cells similar to the platinum complexes such as cis-platin and" exact="carboplatin" post="used in the treatment of cancer. They have many"/>
  <result pre="Orlandi M (−)-Epigallocatechin- 3-gallate downregulates Pg-P and BCRP in a" exact="tamoxifen" post="resistant MCF-7 cell line Phytomedicine 2010 17 356 362"/>
 </snippets>
</snippetsTree>
